|
1) 遠藤玉夫. 筋ジストロフィーと糖鎖-新しい疾患概念α-dystroglycanopathyをめぐって. In: 柳澤信夫, 他編. Annual Review 神経2005. 東京: 中外医学社; 2005. p. 12-9
|
|
|
|
|
2) Chiba A, Matsumura K, Yamada H, et al. Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve α-dystroglycan. The role of a novel Ο-mannosyl-type oligosaccharide in the binding of α-dystroglycan with laminin. J Biol Chem. 1997; 272: 2156-62
|
|
|
|
|
3) Yoshida A, Kobayashi K, Manya H, et al. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell. 2001; 1: 717-24
|
|
|
|
|
|
4) Manya H, Chiba A, Yoshida A, et al. Demonstration of mammalian protein O-mannosyltransferase activity: Coexpression of POMT1 and POMT2 required for enzymatic activity. Proc Natl Acad Sci U S A. 2004; 101: 500-5
|
|
|
|
|
|
5) Endo T. Structure, function and pathology of O-mannosyl glycans. Glycoconj J. 2004; 21: 3-7
|
|
|
|
|
|
6) Michele DE, Campbell KP. Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function. J Biol Chem. 2003; 278: 15457-60
|
|
|
|
|
|
7) Akasaka-Manya K, Manya H, Nakajima A, et al. Physical and functional association of human protein O-mannosyltransferases 1 and 2. J Biol Chem. 2006; 281: 19339-45
|
|
|
|
|
|
8) Manya H, Suzuki T, Akasaka-Manya K, et al. Regulation of mammalian protein O-mannosylation: Preferential amino acid sequence for Ο-mannose modification. J Biol Chem. 2007; 282: 20200-6
|
|
|
|
|
|
9) Breloy I, Schwientek T, Gries B, et al. Initiation of mammalian O-mannosylation in vivo is independent of a consensus sequence and controlled by peptide regions within and upstream of the α-dystroglycan mucin domain. J Biol Chem. 2008; 283: 18832-40
|
|
|
|
|
|
10) Hutzler J, Schmid M, Bernard T, et al. Membrane association is a determinant for substrate recognition by PMT4 protein O-mannosyltransferases. Proc Natl Acad Sci U S A. 2007; 104: 7827-32
|
|
|
|
|
|
11) Kobayashi K, Nakahori Y, Miyake M, et al. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature. 1998; 394: 388-92
|
|
|
|
|
|
12) Xiong H, Kobayashi K, Tachikawa M, et al. Molecular interaction between fukutin and POMGnT1 in the glycosylation pathway of α-dystroglycan. Biochem Biophys Res Commun. 2006; 350: 935-41
|
|
|
|
|
|
13) Barresi R, Michele DE, Kanagawa M, et al. LARGE can functionally bypass α-dystroglycan glycosylation defects in distinct congenital muscular dystrophies. Nat Med. 2004; 10: 696-703
|
|
|
|
|
|
14) Kanagawa M, Saito F, Kunz S, et al. Molecular recognition by LARGE is essential for expression of functional dystroglycan. Cell. 2004; 117: 953-64
|
|
|
|
|
|
15) Beedle AM, Nienaber PM, Campbell KP. Fukutin-related protein associates with the sarcolemmal dystrophin-glycoprotein complex. J Biol Chem. 2007; 282: 16713-7
|
|
|
|
|
|
16) Balci B, Uyanik G, Dincer P, et al. An autosomal recessive limb girdle muscular dystrophy (LGMD2) with mild mental retardation is allelic to Walker-Warburg syndrome (WWS) caused by a mutation in the POMT1 gene. Neuromuscul Disord. 2005; 15: 271-5
|
|
|
|
|
|
17) Muntoni F, Voit T. 133rd ENMC International Workshop on Congenital Muscular Dystrophy (IXth International CMD Workshop) 21-23 January 2005, Naarden, The Netherlands. Neuromuscul Disord. 2005; 15: 794-801
|
|
|
|
|
|
18) Godfrey C, Escolar D, Brockington M, et al. Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy. Ann Neurol. 2006; 60: 603-10
|
|
|
|
|
|
19) Biancheri R, Falace A, Tessa A, et al. POMT2 gene mutation in limb-girdle muscular dystrophy with inflammatory changes. Biochem Biophys Res Commun. 2007; 363: 1033-7
|
|
|
|
|
|
20) Godfrey C, Clement E, Mein R, et al. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain. 2007; 130: 2725-35
|
|
|
|
|
|
21) Clement EM, Godfrey C, Tan J, et al. Mild POMGnT1 mutations underlie a novel limb-girdle muscular dystrophy variant. Arch Neurol. 2008; 65: 137-41
|
|
|
|
|
|
22) Manya H, Bouchet C, Yanagisawa A, et al. Protein O-mannosyltransferase activities in lymphoblasts from patients with α-dystroglycanopathies. Neuromuscul Disord. 2008; 18: 45-51
|
|
|
|
|
|
23) Patnaik SK, Stanley P. Mouse large can modify complex N- and mucin O-glycans onα-dystroglycan to induce laminin binding. J Biol Chem. 2005; 280: 20851-9
|
|
|
|
|
|
24) Mercuri E, Brockington M, Straub V, et al. Phenotypic spectrum associated with mutations in the fukutin-related protein gene. Ann Neurol. 2003; 53: 537-42
|
|
|
|
|
|
25) Brown SC, Torelli S, Brockington M, et al. Abnormalities in α-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies. Am J Pathol. 2004; 164: 727-37
|
|
|
|
|
|
26) Murakami T, Hayashi YK, Noguchi S, et al. Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness. Ann Neurol. 2006; 60: 597-602
|
|
|
|
|